Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Added Value of Contrast Enhanced Mammography (CEM) to Standard Mammography in Assessing the Extent of Ductal Carcinoma in Situ (DCIS)

NCT06217458 is registered in ClinicalTrials.gov with Clinical Hospital Center Rijeka as lead sponsor.

NCT NCT06217458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06217458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Added Value of Contrast Enhanced Mammography (CEM) to Standard Mammography in Assessing the Extent of Ductal Carcinoma in Situ (DCIS)
Lead sponsor
Clinical Hospital Center Rijeka
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
January 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast carcinoma in situ, calcification, dcis